IP Library › Granted Patent US 10,500,309
Granted Patent B2
US 10,500,309 · App. 12/236,751 · Granted Dec 10, 2019

Absorbable adhesives and their formulation for use in medical applications

Inventors: Bhavin Shah (West Lafayette, IN); Paul J. Hall (Lafayette, IN)
Assignee: Cook Biotech Incorporated
A61L27/3633A61L24/104A61L27/34A61L27/3629
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,500,309
App. No.
12/236,751
Filed
Sep 24, 2008
Granted
Dec 10, 2019
Kind
B2
Art Unit
1611
USPC
424/422
Abstract

Described are medical products including an adhesive containing a polypeptide component such as gelatin and a tackiness-providing polyhydroxy compound, such as at least one compound selected from the group consisting of glycerin and fructose. Such medical products can find use as a bolster material for use in conjunction with a surgical fastening device such as a stapler. Other medical applications utilizing a medical product of the invention include tissue repair and pharmaceutical delivery to a desired location. Related methods of manufacture and use are also described.

Claims (30)

1. A medical product, comprising:

a medical graft material; and

a dried, reversible adhesive coating on at least a portion of a surface of said material, wherein said adhesive coating comprises a mixture of gelatin and fructose, wherein said fructose is present in the adhesive coating in an amount greater than that of said gelatin by dry weight ratio and in an amount of 1 to 10 mg/cm 2 , wherein said adhesive coating has a dry weight ratio of gelatin to fructose of 30:70 to 50:50, wherein said adhesive coating comprises a layer present at a level of 2 mg/cm 2 to 100 mg/cm 2 ; and wherein said reversible adhesive coating is suitable when wetted to attach said medical graft material to a surgical device while allowing for the release of the medical graft material from the surgical device upon implantation.

2. The medical product of claim 1 , wherein said reversible adhesive coating is non-tacky when dried, and wherein said reversible adhesive coating becomes tacky when moistened.

3. The medical product of claim 1 , wherein said medical graft material is comprised of a biological material.

4. The medical product of claim 3 , wherein said medical graft material is remodelable.

5. The medical product of claim 4 , wherein said medical graft material comprises an extracellular matrix (ECM) material.

6. The medical product of claim 5 , wherein said ECM comprises submucosa.

7. The medical product of claim 6 , wherein said submucosa is intestinal, urinary bladder or stomach submucosa.

8. The medical product of claim 7 , wherein said submucosa is small intestinal submucosa (SIS).

9. The medical product of claim 1 , wherein said medical product is useful as a bolster material.

10. The medical product of claim 9 , wherein said bolster material is configured for application to an arm of a surgical fastening device.

11. The medical product of claim 1 , wherein said medical product is useful as a hernia repair graft.

12. The medical product of claim 1 , wherein said adhesive is dried to form a porous open-cell foam.

13. The medical product of claim 1 , wherein said adhesive further comprises a bioactive component and/or pharmaceutical agent.

14. The medical product of claim 1 , wherein said adhesive is coated onto a substantial portion of the medical material.

15. The medical product of claim 1 , wherein said adhesive is air dried.

16. The medical product of claim 1 , wherein said adhesive is vacuum dried.

17. A medical product for use with a surgical device, said medical product comprising:

a layer of dried, collagenous extracellular matrix material; and

a dried, reversible adhesive coating on at least a portion of a surface of said layer, wherein said adhesive comprises a mixture of gelatin and fructose, wherein said mixture contains a greater amount of fructose than gelatin on a dry weight basis, wherein said adhesive coating has a dry weight ratio of gelatin to fructose of 30:70 to 50:50, and wherein said reversible adhesive coating is suitable when wetted to attach said medical graft material to the surgical device while allowing for the release of the medical graft material from the surgical device upon implantation.

18. The medical product of claim 17 , wherein said layer and said coating are lyophilized.

19. The medical product of claim 17 , wherein said layer comprises submucosa of a warm-blooded vertebrate.

20. The medical product of claim 19 , wherein said layer comprises small intestinal submucosa.

21. The medical product of claim 17 , wherein said adhesive is air dried.

22. The medical product of claim 17 , wherein said adhesive is vacuum dried.

23. A bolster material, comprising:

bolster material configured for application to an arm of a surgical fastening device; and

a dried, reversible adhesive coating on at least a portion of a surface of said bolster material, wherein said adhesive comprises a mixture of gelatin and fructose, and wherein said gelatin is present in the adhesive in an amount of 1 to 5 mg/cm 2 , wherein said fructose is present in the adhesive in an amount greater than that of said gelatin by dry weight, wherein said adhesive comprises at least 30% but less than 50% gelatin on a dry weight basis, and wherein said reversible adhesive coating is suitable when wetted to attach said bolster material to the arm of the surgical fastening device while allowing for the release of the bolster material from the arm of the surgical fastening device upon implantation.

24. The bolster material of claim 23 , wherein said adhesive coating has a dry weight ratio of gelatin to fructose of 30:70 to 50:50.

Assignments (4)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: COOK BIOTECH INCORPORATED
Reel/Frame 072938/0231 →
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
SECURITY INTEREST Recorded Apr 3, 2024
From: COOK BIOTECH INCORPORATED
To: ARES CAPITAL CORPORATION, AS SECURITY AGENT
Reel/Frame 067001/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2008
From: SHAH, BHAVIN; HALL, PAUL J.
To: COOK BIOTECH INCORPORATED
Reel/Frame 021584/0800 →
Continuity (2)
Provisional Application 60977680 · Oct 5, 2007
Related Publication 20090092651A1 · Apr 9, 2009
Cited By (60)
US 12,185,946 US 12,207,820 US 12,207,835 US 12,213,666 US 12,213,671 US 12,220,126 US 12,226,099 US 12,226,100 US 12,232,723 US 12,232,724 US 12,239,316 US 12,239,317 US 12,245,764 US 12,245,901 US 12,256,930 US 12,256,931 US 12,261,471 US 12,262,888 US 12,274,438 US 12,274,442 US 12,274,445 US 12,285,166 US 12,285,171 US 12,290,259 US 12,290,261 US 12,324,579 US 12,324,580 US 12,324,581 US 12,324,585 US 12,336,705 US 12,336,709 US 12,343,013 US 12,357,309 US 12,369,909 US 12,369,911 US 12,369,912 US 12,383,259 US 12,383,267 US 12,414,768 US 12,432,790 US 12,433,584 US 12,433,590 US 12,433,627 US 12,440,208 US 12,440,209 US 12,440,213 US 12,446,877 US 12,453,557 US 12,458,455 US 12,465,363 US 12,471,982 US 12,502,171 US 12,508,025 US 12,521,116 US 12,527,571 US 12,527,575 US 12,533,126 US 12,533,127 US 12,636,006 US 12,714,425